Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?
作者信息
Trojan J, Stuermer M, Teuber G, Berger A, Faust D
出版信息
Gut. 2007 Mar;56(3):436-7; author reply 437. doi: 10.1136/gut.2006.108928.
Abstract
摘要
相似文献
1
Treatment of patients with lamivudine-resistant and adefovir dipivoxil-resistant chronic hepatitis B virus infection: is tenofovir the answer?拉米夫定耐药且阿德福韦酯耐药的慢性乙型肝炎病毒感染患者的治疗：替诺福韦是答案吗？
Gut. 2007 Mar;56(3):436-7; author reply 437. doi: 10.1136/gut.2006.108928.
2
Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis.与在拉米夫定耐药的B型慢性肝炎患者中加用阿德福韦酯的治疗效果相关的突变
J Med Virol. 2009 May;81(5):798-806. doi: 10.1002/jmv.21348.
3
Long-term therapy with adefovir dipivoxil in hepatitis B e antigen-negative patients developing resistance to lamivudine.阿德福韦酯对拉米夫定耐药的乙肝e抗原阴性患者的长期治疗
Aliment Pharmacol Ther. 2008 Feb 1;27(3):266-73. doi: 10.1111/j.1365-2036.2007.03567.x. Epub 2007 Nov 5.
4
Adefovir dipivoxil for the treatment of lamivudine-resistant hepatitis B mutants.阿德福韦酯用于治疗对拉米夫定耐药的乙型肝炎突变体。
Hepatobiliary Pancreat Dis Int. 2006 Feb;5(1):154-6.
5
Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir.阿德福韦酯治疗后病毒学应答不佳的拉米夫定耐药慢性乙型肝炎患者的治疗选择
Aliment Pharmacol Ther. 2011 Oct;34(8):972-81. doi: 10.1111/j.1365-2036.2011.04833.x. Epub 2011 Aug 24.
6
Severe exacerbation of chronic hepatitis B after emergence of lamivudine resistance in a cirrhotic patient: immediate switch to adefovir dipivoxil appears to be indicated.一名肝硬化患者出现拉米夫定耐药后慢性乙型肝炎严重恶化：似乎应立即换用阿德福韦酯。
Z Gastroenterol. 2004 Jan;42(1):15-8. doi: 10.1055/s-2004-812683.
7
Clinical course and predictive factors of virological response in long-term lamivudine plus adefovir dipivoxil combination therapy for lamivudine-resistant chronic hepatitis B patients.长期拉米夫定联合阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎患者的临床过程及病毒学应答的预测因素。
J Med Virol. 2011 Jun;83(6):953-61. doi: 10.1002/jmv.22025.
8
9
Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.阿德福韦单药治疗与拉米夫定联合阿德福韦治疗期间拉米夫定耐药乙型肝炎病毒的动态变化
J Med Virol. 2008 Jul;80(7):1160-70. doi: 10.1002/jmv.21206.
10
Tenofovir disoproxil fumarate rescue therapy following failure of both lamivudine and adefovir dipivoxil in chronic hepatitis B.富马酸替诺福韦二吡呋酯挽救治疗拉米夫定和阿德福韦酯治疗失败的慢性乙型肝炎。
Gut. 2011 Feb;60(2):247-54. doi: 10.1136/gut.2010.223206. Epub 2010 Oct 29.
引用本文的文献
1
Hepatitis B virus genotype C encoding resistance mutations that emerge during adefovir dipivoxil therapy: in vitro replication phenotype.在阿德福韦酯治疗期间出现编码耐药突变的乙型肝炎病毒C基因型：体外复制表型
Hepatol Int. 2013 Jun;7(2):443-50. doi: 10.1007/s12072-012-9411-2. Epub 2012 Nov 28.
2
Antiviral drug resistance: mechanisms and clinical implications.抗病毒药物耐药性：机制与临床意义。
Infect Dis Clin North Am. 2010 Jun;24(2):413-37. doi: 10.1016/j.idc.2010.01.001.
本文引用的文献
1
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy.替诺福韦用于拉米夫定耐药的乙型肝炎病毒（HBV）感染患者且在阿德福韦治疗期间HBV DNA水平较高者。
Hepatology. 2006 Aug;44(2):318-25. doi: 10.1002/hep.21253.
2
Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients.替诺福韦酯对HIV感染患者的抗乙型肝炎病毒疗效
Hepatology. 2006 Mar;43(3):548-55. doi: 10.1002/hep.21055.
3
Impact of tenofovir-containing antiretroviral therapy on chronic hepatitis B in a cohort co-infected with human immunodeficiency virus.含替诺福韦的抗逆转录病毒疗法对人类免疫缺陷病毒合并感染队列中慢性乙型肝炎的影响。
J Antimicrob Chemother. 2005 Dec;56(6):1087-93. doi: 10.1093/jac/dki396. Epub 2005 Nov 3.
4
Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation.阿德福韦耐药的乙型肝炎可能与病毒反弹和肝脏失代偿有关。
J Hepatol. 2005 Dec;43(6):937-43. doi: 10.1016/j.jhep.2005.05.037. Epub 2005 Jul 7.
5
Comparison of adefovir and tenofovir in the treatment of lamivudine-resistant hepatitis B virus infection.阿德福韦与替诺福韦治疗拉米夫定耐药乙型肝炎病毒感染的比较。
Hepatology. 2004 Dec;40(6):1421-5. doi: 10.1002/hep.20464.
Zotero 插件